Form N-Q LEGG MASON PARTNERS EQUI For: Jan 31

SCHEDULE OF INVESTMENTS.

SECURITY

Diversified Telecommunication Services - 1.4%

KT Corp.

Telecom Italia SpA

Total Diversified Telecommunication Services

Interactive Media & Services - 0.5%

Baidu Inc., ADR

Wireless Telecommunication Services - 1.3%

Vodafone Group PLC

TOTAL COMMUNICATION SERVICES

Automobiles - 4.3%

Bayerische Motoren Werke AG

Honda Motor Co., Ltd.

Total Automobiles

Household Durables - 1.1%

Sony Corp.

Textiles, Apparel & Luxury Goods - 3.9%

ANTA Sports Products Ltd.

Capri Holdings Ltd.

PRADA SpA

Total Textiles, Apparel & Luxury Goods

TOTAL CONSUMER DISCRETIONARY

Beverages - 1.3%

Diageo PLC

Food Products - 2.3%

Danone SA

Thai Union Group PCL, Class F Shares

Total Food Products

Tobacco - 1.5%

Imperial Brands PLC

TOTAL CONSUMER STAPLES

Energy Equipment & Services - 1.2%

Saipem SpA

Oil, Gas & Consumable Fuels - 6.4%

BP PLC

Encana Corp.

SECURITY

Oil, Gas & Consumable Fuels - (continued)

Royal Dutch Shell PLC, Class A Shares

Total SA

Total Oil, Gas & Consumable Fuels

TOTAL ENERGY

Banks - 17.7%

Banco Santander SA

Bangkok Bank PCL, Registered Shares

Barclays PLC

BAWAG Group AG

BNP Paribas SA

China Construction Bank Corp., Class H Shares

Royal Bank of Scotland Group PLC

Shinhan Financial Group Co., Ltd.

Standard Chartered PLC

Sumitomo Mitsui Financial Group Inc.

Turkiye Garanti Bankasi AS

UniCredit SpA

Total Banks

Capital Markets - 5.0%

Credit Suisse Group AG, Registered Shares

Daiwa Securities Group Inc.

Korea Investment Holdings Co., Ltd.

UBS Group AG, Registered Shares

Total Capital Markets

Diversified Financial Services - 1.7%

Far East Horizon Ltd.

Standard Life Aberdeen PLC

Total Diversified Financial Services

Insurance - 2.3%

Aviva PLC

AXA SA

Total Insurance

TOTAL FINANCIALS

Pharmaceuticals - 11.0%

Allergan PLC

Bayer AG, Registered Shares

Mylan NV

Novartis AG, Registered Shares

SECURITY

Pharmaceuticals - (continued)

Roche Holding AG

Teva Pharmaceutical Industries Ltd., ADR

TOTAL HEALTH CARE

Airlines - 0.5%

Cathay Pacific Airways Ltd.

Commercial Services & Supplies - 1.1%

G4S PLC

Construction & Engineering - 1.4%

Bouygues SA

China Machinery Engineering Corp., Class H Shares

Total Construction & Engineering

Electrical Equipment - 2.2%

Schneider Electric SE

Sensata Technologies Holding PLC

Total Electrical Equipment

Machinery - 3.6%

CIMC Enric Holdings Ltd.

CNH Industrial NV

KION Group AG

Tadano Ltd.

Takeuchi Manufacturing Co., Ltd.

Total Machinery

Marine - 1.6%

A.P. Moller-Maersk A/S, Class B Shares

Professional Services - 1.2%

Adecco Group AG, Registered Shares

Road & Rail - 1.0%

Europcar Mobility Group

TOTAL INDUSTRIALS

Electronic Equipment, Instruments & Components - 2.3%

Hitachi Ltd.

IT Services - 3.0%

Cielo SA

Infosys Ltd., ADR

TravelSky Technology Ltd., Class H Shares

Total IT Services

SECURITY

Semiconductors & Semiconductor Equipment - 0.7%

Ambarella Inc.

TOTAL INFORMATION TECHNOLOGY

Chemicals - 5.2%

Akzo Nobel NV

BASF SE

Incitec Pivot Ltd.

Nutrien Ltd.

Total Chemicals

Construction Materials - 1.6%

Cemex SAB de CV, Participation Certificates, ADR

Wienerberger AG

Total Construction Materials

Containers & Packaging - 1.1%

Greatview Aseptic Packaging Co., Ltd.

Metals & Mining - 5.0%

Newcrest Mining Ltd.

Novagold Resources Inc.

POSCO

Rio Tinto Ltd.

thyssenkrupp AG

Total Metals & Mining

Paper & Forest Products - 1.3%

Duratex SA

TOTAL MATERIALS

TOTAL INVESTMENTS BEFORE SHORT-TERM INVESTMENTS

(Cost - $391,714,226)

JPMorgan 100% U.S. Treasury Securities Money Market Fund, Institutional Class
(Cost - $15,611,074)

TOTAL INVESTMENTS - 99.7%
(Cost - $407,325,300)

Other Assets in Excess of Liabilities - 0.3%

TOTAL NET ASSETS - 100.0%

Non-income producing security.

Security is valued in good faith in accordance with procedures approved by the Board of Trustees (Note 1).

Security is exempt from registration under Rule 144A of the Securities Act of 1933. This security may be resold in transactions that are exempt from registration, normally to qualified institutional buyers. This security has been deemed liquid pursuant to guidelines approved by the Board of Trustees.

Level 1 – quoted prices in active markets for identical investments

Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

Level 3 – significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)

ASSETS

DESCRIPTION

Long-Term Investments†:

Common Stocks:

Communication Services

Consumer Discretionary

Energy

Health Care

Industrials

Information Technology

Materials

Other Common Stocks

Total Long-Term Investments

Short-Term Investments†

Total Investments

See Schedule of Investments for additional detailed categorizations.

CONTROLS AND PROCEDURES.

The registrant’s principal executive officer and principal financial officer have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a- 3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing date of this report that includes the disclosure required by this paragraph, based on their evaluation of the disclosure controls and procedures required by Rule 30a-3(b) under the 1940 Act and 15d-15(b) under the Securities Exchange Act of 1934.

There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the registrant’s last fiscal quarter that have materially affected, or are likely to materially affect the registrant’s internal control over financial reporting.

EXHIBITS.

Date:

March 14, 2019

Date:

March 14, 2019

Date:

March 14, 2019

I have reviewed this report on Form N-Q of Legg Mason Partners Equity Trust – ClearBridge International Value Fund;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the schedule of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 14, 2019

I have reviewed this report on Form N-Q of Legg Mason Partners Equity Trust – ClearBridge International Value Fund;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the schedule of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 14, 2019